Overall rank by patents
#6,539
of 50,000 tracked assignees
USPTO PatentsView assignee record - 51 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
According to USPTO PatentsView, Helsinn ranks #6,539 of 50,000 tracked US assignees by granted-patent volume, with 51 patents across 9 technology areas.
USPTO PatentsView assignee plate
Corpus R6539 · Foreign Corporation #6,539 · 51 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Glenmark Pharmaceuticals S.a. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Heifeng Zhizao (shen… · near
40 score
Helsinn Healthcare · this assignee
40 score
Lagom Kitchen · near
40 score
Mid-west Metal Produ… · near
40 score
Peridot Print · near
40 score
3D Lighting Innovati… · lowest
7 score
What this shows Helsinn Healthcare Sa stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-NARROW, INNOV-THIN, CLAIMS-RICH, TYPE-FRNCORP, VEL-DOWN, BOOK-FULL. Volume places it #6,539 of 50,000; Innovation Score 40.0/100 sits in the top 37% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Glenmark Pharmaceuticals S.a. (±0 grants).
Helsinn Healthcare Sa has been granted 51 US utility patents between 2015 and 2025, placing Helsinn Healthcare Sa at #6,539 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.8 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Helsinn Healthcare Sa is one of the more focused assignees in the PatentsView dataset. By volume, Helsinn sits between Guangdong Bestek E-commerce Co., Ltd. (51 patents, rank #6,535) and Integrity Security Services Llc (51 patents, rank #6,543) - the closest US assignees by grant volume. The composite Innovation Score of 40.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 19 grants, compared with 31 in the 2015–2019 window, a -39% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Helsinn Healthcare Sa's 18.8 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 9 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
GUANGDONG BESTEK E-COMMERCE CO., LTD.
51 patents
GUANGZHOU TYRAFOS SEMICONDUCTOR TECHNOLOGIES CO., LTD.
51 patents
Glenmark Pharmaceuticals S.A.
51 patents
Glock Technology GmbH
51 patents
Howmet Aerospace Inc.
51 patents
INERGY AUTOMOTIVE SYSTEMS RESEARCH (Societe Anonyme)
51 patents
INHA-INDUSTRY PARTNERSHIP INSTITUTE
51 patents
INTEGRITY SECURITY SERVICES LLC
51 patents
Helsinn Healthcare SA
51 patents
What this shows Helsinn holds 51 patents at rank #6,539, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #6,539 in granted patent volume.
Other assignees with the most granted patents in Helsinn's primary technology class.
Two PlainPatent-derived peer sets for Helsinn, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (40 here).
Nearest assignees by average claims per patent (18.8 here).
Helsinn's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 9.8% |
| 2016 | 8 | 15.7% |
| 2017 | 3 | 5.9% |
| 2018 | 9 | 17.6% |
| 2019 | 6 | 11.8% |
| 2020 | 6 | 11.8% |
| 2021 | 3 | 5.9% |
| 2022 | 3 | 5.9% |
| 2023 | 2 | 3.9% |
| 2024 | 5 | 9.8% |
| 2025partial year | 1 | 2.0% |
Top 9 of 9 technology areas
Overall rank by patents
#6,539
of 50,000 tracked assignees
40.0 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.